<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7097340/results/search/disease/results.xml">
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="Organization (WHO) declaration of COVID-19 as a global pandemic. Abstract" exact="Viral" post="infections affect three to five million patients annually. While"/>
  <result pre="(WHO) declaration of COVID-19 as a global pandemic. Abstract Viral" exact="infections" post="affect three to five million patients annually. While commonly"/>
  <result pre="five million patients annually. While commonly used antivirals often show" exact="limited" post="efficacy and serious adverse effects, herbal extracts have been"/>
  <result pre="naturally based pharmacotherapy may be a proper alternative for treating" exact="viral" post="diseases. With that in mind, various pharmaceutical formulations and"/>
  <result pre="Antiviral Phytomedicine Herbal extracts Flavonoid Solubility Oral drug delivery Introduction" exact="Viral" post="infections remain a major worldwide cause of morbidity and"/>
  <result pre="Phytomedicine Herbal extracts Flavonoid Solubility Oral drug delivery Introduction Viral" exact="infections" post="remain a major worldwide cause of morbidity and mortality."/>
  <result pre="worldwide cause of morbidity and mortality. Among the most aggressive" exact="viral" post="infections are Ebola, AIDS (acquired immunodeficiency syndrome), influenza, and"/>
  <result pre="cause of morbidity and mortality. Among the most aggressive viral" exact="infections" post="are Ebola, AIDS (acquired immunodeficiency syndrome), influenza, and SARS"/>
  <result pre="Among the most aggressive viral infections are Ebola, AIDS (acquired" exact="immunodeficiency" post="syndrome), influenza, and SARS (severe acute respiratory syndrome). For"/>
  <result pre="are Ebola, AIDS (acquired immunodeficiency syndrome), influenza, and SARS (severe" exact="acute" post="respiratory syndrome). For instance, influenza is responsible for over"/>
  <result pre="Ebola, AIDS (acquired immunodeficiency syndrome), influenza, and SARS (severe acute" exact="respiratory" post="syndrome). For instance, influenza is responsible for over 3"/>
  <result pre="yearly [1, 2]. Alarmingly, the number of patients diagnosed with" exact="viral" post="infections is increasing every year with more blood transfusions,"/>
  <result pre="[1, 2]. Alarmingly, the number of patients diagnosed with viral" exact="infections" post="is increasing every year with more blood transfusions, organ"/>
  <result pre="blood transfusions, organ transplantations, and the use of hypodermic syringes." exact="Classic" post="antiviral drugs such as interferon and ribavirin are effective"/>
  <result pre="treat a selection of viruses; these viruses include HIV (human" exact="immunodeficiency" post="virus), herpes viruses, including HSV (herpes simplex virus), hCMV"/>
  <result pre="selection of viruses; these viruses include HIV (human immunodeficiency virus)," exact="herpes" post="viruses, including HSV (herpes simplex virus), hCMV (human cytomegalovirus),"/>
  <result pre="including HSV (herpes simplex virus), hCMV (human cytomegalovirus), VZV (varicella" exact="zoster" post="virus), influenza viruses, and the hepatitis viruses (Fig. 1)."/>
  <result pre="(human cytomegalovirus), VZV (varicella zoster virus), influenza viruses, and the" exact="hepatitis" post="viruses (Fig. 1). Currently, there is no approved remedy"/>
  <result pre="approved remedy for many types or viruses, and vaccination is" exact="limited" post="to hepatitis A virus, mumps, and varicella [2]. In"/>
  <result pre="for many types or viruses, and vaccination is limited to" exact="hepatitis" post="A virus, mumps, and varicella [2]. In addition, these"/>
  <result pre="and vaccination is limited to hepatitis A virus, mumps, and" exact="varicella" post="[2]. In addition, these agents are often costly and"/>
  <result pre="addition, these agents are often costly and ineffective due to" exact="viral" post="resistance and cause side effects. With that in mind,"/>
  <result pre="naturally based pharmacotherapy may be a proper alternative for treating" exact="viral" post="diseases. Thus, it is necessary to further examine the"/>
  <result pre="Antiviral drugs. The antiviral drugs are used for HIV (human" exact="immunodeficiency" post="virus), herpes viruses, influenza A and B viruses, and"/>
  <result pre="The antiviral drugs are used for HIV (human immunodeficiency virus)," exact="herpes" post="viruses, influenza A and B viruses, and the HBV"/>
  <result pre="their strong therapeutic effect. In traditional medicine, diseases of possible" exact="viral" post="origin have been treated by many of these plants."/>
  <result pre="HBV Epigallocathechin-3-gallate [8] Capparis spinosa Methanolic extract HSV-2 HIV-1 Unknown" exact="Protein" post="[9] Cassine xylocarpa Aqueous extract HIV Pentacyclic lupane-type triterpenoids"/>
  <result pre="HIV Pentacyclic lupane-type triterpenoids [10] Cistus incanus Polyphenol-rich extract (CYSTUS052)" exact="Avian" post="and human influenza strains of different subtypes HIV-1 and"/>
  <result pre="vitexin, apigenin-7-O-glucoside [6] Dittrichia viscosa Aqueous extract VSV, HSV-1, poliovirus" exact="type 1" post="Unknown [16] Euphorbia hirta Aqueous extracts, methanol extracts HIV-1,"/>
  <result pre="Methanolic extract NDV Unknown [22] Glycyrrhiza uralensis Metabolic extract Rotavirus" exact="diarrhea" post="Unknown [23] Hyssopus officinalis Methanolic extract HSV-1 Unknown [5]"/>
  <result pre="Ethanol extract HSV-1, HSV-2 Kaempferol [25] Magnolia officinalis Methanol extract" exact="Dengue" post="virus Type 2 Honokiol [26] Maytenus cuzcoina Aqueous extract"/>
  <result pre="HSV-1, HSV-2 Kaempferol [25] Magnolia officinalis Methanol extract Dengue virus" exact="Type 2" post="Honokiol [26] Maytenus cuzcoina Aqueous extract HIV Pentacyclic lupane-type"/>
  <result pre="[3] Taraxacum officinale Methanol extract Aqueous extract HCV Influenza virus" exact="type A," post="H1N1. Unknown [42] [43] Thymus carmanicus Methanol extract HIV-1"/>
  <result pre="[6] Zataria multiflora Methanolic extract HSV-1 Rosmarinic acid [47] HSV" exact="herpes" post="simplex virus, VSV vesicular stomatitis virus, HBV hepatitis B"/>
  <result pre="HSV-1 Rosmarinic acid [47] HSV herpes simplex virus, VSV vesicular" exact="stomatitis" post="virus, HBV hepatitis B virus, HIV human immunodeficiency virus,"/>
  <result pre="[47] HSV herpes simplex virus, VSV vesicular stomatitis virus, HBV" exact="hepatitis" post="B virus, HIV human immunodeficiency virus, SIV simian immunodeficiency"/>
  <result pre="VSV vesicular stomatitis virus, HBV hepatitis B virus, HIV human" exact="immunodeficiency" post="virus, SIV simian immunodeficiency virus, ECV echovirus, ADV adenovirus,"/>
  <result pre="HBV hepatitis B virus, HIV human immunodeficiency virus, SIV simian" exact="immunodeficiency" post="virus, ECV echovirus, ADV adenovirus, NDV Newcastle disease virus,"/>
  <result pre="virus, SIV simian immunodeficiency virus, ECV echovirus, ADV adenovirus, NDV" exact="Newcastle disease" post="virus, HCV hepatitis C virus Various phytochemicals were isolated,"/>
  <result pre="SIV simian immunodeficiency virus, ECV echovirus, ADV adenovirus, NDV Newcastle" exact="disease" post="virus, HCV hepatitis C virus Various phytochemicals were isolated,"/>
  <result pre="virus, ECV echovirus, ADV adenovirus, NDV Newcastle disease virus, HCV" exact="hepatitis" post="C virus Various phytochemicals were isolated, purified, and identified"/>
  <result pre="a flavonoid glycoside common in different plants, is effective against" exact="avian influenza" post="virus [48], HSV-1, HSV-2 [18], and parainfluenza-3 virus [49]."/>
  <result pre="poliovirus [54], adenovirus [53], Epstein-Barr virus [55], Mayaro virus [56]," exact="Japanese encephalitis" post="virus [57], respiratory syncytial virus [58], and HCV [59,"/>
  <result pre="[54], adenovirus [53], Epstein-Barr virus [55], Mayaro virus [56], Japanese" exact="encephalitis" post="virus [57], respiratory syncytial virus [58], and HCV [59,"/>
  <result pre="Epstein-Barr virus [55], Mayaro virus [56], Japanese encephalitis virus [57]," exact="respiratory" post="syncytial virus [58], and HCV [59, 60]. Its antiviral"/>
  <result pre="to stress which were involved in NS5A (nonstructural protein 5A)-mediated" exact="viral" post="IRES (internal ribosome entry site) translation [60] is one"/>
  <result pre="also inhibits various steps of the rhinoviruses pathogenesis, i.e., endocytosis," exact="viral" post="genome transcription, and protein synthesis [51]. In another case,"/>
  <result pre="replication of dengue virus type-2, but not the processes of" exact="viral" post="attachment and entry [52]. In addition, quercetin and three"/>
  <result pre="5,6,7-trihydroxyflavone (baicalein), all effectively inhibited reverse transcriptases from Rauscher murine" exact="leukemia" post="virus (RLV) and HIV; quercetin, myricetin, and quercetagetin were"/>
  <result pre="has broad antiviral activities against enterovirus-71 [63], foot and mouth" exact="disease" post="virus [64], HCV [65], African swine fever virus (ASFV)"/>
  <result pre="enterovirus-71 [63], foot and mouth disease virus [64], HCV [65]," exact="African" post="swine fever virus (ASFV) [66], and influenza A virus"/>
  <result pre="baicalein, biochanin A, kaempferol, luteolin, naringenin) were active against the" exact="avian influenza" post="H5N1 virus in human lung epithelial (A549) cells through"/>
  <result pre="active against the avian influenza H5N1 virus in human lung" exact="epithelial" post="(A549) cells through inhibiting nucleoprotein production [67]. Baicalin (the"/>
  <result pre="wide range of viruses, including enterovirus [68], dengue virus [69]," exact="respiratory" post="syncytial virus [70], Newcastle disease virus [71], human immunodeficiency"/>
  <result pre="including enterovirus [68], dengue virus [69], respiratory syncytial virus [70]," exact="Newcastle disease" post="virus [71], human immunodeficiency virus [72], and hepatitis B"/>
  <result pre="enterovirus [68], dengue virus [69], respiratory syncytial virus [70], Newcastle" exact="disease" post="virus [71], human immunodeficiency virus [72], and hepatitis B"/>
  <result pre="[69], respiratory syncytial virus [70], Newcastle disease virus [71], human" exact="immunodeficiency" post="virus [72], and hepatitis B virus [73], and different"/>
  <result pre="[70], Newcastle disease virus [71], human immunodeficiency virus [72], and" exact="hepatitis" post="B virus [73], and different mechanisms were suggested for"/>
  <result pre="example, baicalin inhibits the production of HBV, the templates for" exact="viral" post="proteins and HBV-DNA synthesis [73], and decreases IL-6 and"/>
  <result pre="without affecting IP-10 levels, as shown in a study on" exact="avian influenza" post="H5N1 virus [67]. The triterpenoids oleanolic acid and ursolic"/>
  <result pre="phytochemical drug formulations due to enhanced solubility and oral absorption," exact="systemic" post="bioavailability, safety, delayed metabolism, and better overall antiviral activity."/>
  <result pre="In vitro drug release testing demonstrated that myricetin alone had" exact="limited" post="dissolution of 51% after an hour, whereas drug release"/>
  <result pre="(SPIP) method in rats showed that in the duodenum, the" exact="primary" post="absorption site of myricetin, the effective permeability coefficient was"/>
  <result pre="13 in Fig. 2 had higher intestinal permeability, but showed" exact="lower" post="bioavailability attributed to poor lymphatic transport—a main absorption mechanism"/>
  <result pre="HCV, ZIKV, CHIKV, norovirus, HIV, HPV, CMV, EV71, DENV type-2" exact="Mixed" post="micelles [129, 130], nanoparticles [131, 132], solid dispersion [133,"/>
  <result pre="Inclusion complex [148], conjugate micelles [149], nanoparticles [150] Oleanolic acid" exact="Acute" post="and chronic hepatitis SMEDDS [151], nanoparticles [152], nanosuspensions [153,"/>
  <result pre="[148], conjugate micelles [149], nanoparticles [150] Oleanolic acid Acute and" exact="chronic hepatitis" post="SMEDDS [151], nanoparticles [152], nanosuspensions [153, 154] , SNEDDS"/>
  <result pre="conjugate micelles [149], nanoparticles [150] Oleanolic acid Acute and chronic" exact="hepatitis" post="SMEDDS [151], nanoparticles [152], nanosuspensions [153, 154] , SNEDDS"/>
  <result pre="nanoparticles [152], nanosuspensions [153, 154] , SNEDDS [155] HIV human" exact="immunodeficiency" post="virus, RLV rhesus lymphocryptovirus, FMDV foot and mouth disease"/>
  <result pre="human immunodeficiency virus, RLV rhesus lymphocryptovirus, FMDV foot and mouth" exact="disease" post="virus, HCV hepatitis C virus, ASFV African swine fever"/>
  <result pre="RLV rhesus lymphocryptovirus, FMDV foot and mouth disease virus, HCV" exact="hepatitis" post="C virus, ASFV African swine fever virus, NDV Newcastle"/>
  <result pre="foot and mouth disease virus, HCV hepatitis C virus, ASFV" exact="African" post="swine fever virus, NDV Newcastle disease virus, DENV dengue"/>
  <result pre="HCV hepatitis C virus, ASFV African swine fever virus, NDV" exact="Newcastle disease" post="virus, DENV dengue virus, RSV respiratory syncytial virus, HBV"/>
  <result pre="hepatitis C virus, ASFV African swine fever virus, NDV Newcastle" exact="disease" post="virus, DENV dengue virus, RSV respiratory syncytial virus, HBV"/>
  <result pre="fever virus, NDV Newcastle disease virus, DENV dengue virus, RSV" exact="respiratory" post="syncytial virus, HBV hepatitis B virus, JEV Japanese encephalitis"/>
  <result pre="disease virus, DENV dengue virus, RSV respiratory syncytial virus, HBV" exact="hepatitis" post="B virus, JEV Japanese encephalitis virus, EBV Epstein–Barr virus,"/>
  <result pre="virus, RSV respiratory syncytial virus, HBV hepatitis B virus, JEV" exact="Japanese encephalitis" post="virus, EBV Epstein–Barr virus, MAYV Mayaro virus, RV rhinovirus,"/>
  <result pre="RSV respiratory syncytial virus, HBV hepatitis B virus, JEV Japanese" exact="encephalitis" post="virus, EBV Epstein–Barr virus, MAYV Mayaro virus, RV rhinovirus,"/>
  <result pre="MAYV Mayaro virus, RV rhinovirus, CHIKV Chikungunya virus, HPV human" exact="papilloma" post="virus, HSV herpes simplex virus, ZIKV Zika virus, CMV"/>
  <result pre="RV rhinovirus, CHIKV Chikungunya virus, HPV human papilloma virus, HSV" exact="herpes" post="simplex virus, ZIKV Zika virus, CMV cytomegalovirus, EV enterovirus,"/>
  <result pre="or any of four different SNEDDS formulations (n = 6);" exact="upper" post="right: permeability coefficient (Peff) of myricetin in single-pass intestinal"/>
  <result pre="(P123, an amphipathic polymer and sodium taurocholate as a carrier);" exact="upper" post="right: drug release of baicalin. Reproduced from [94] with"/>
  <result pre="[94] with permission Oleanolic acid has low aqueous solubility and" exact="systemic" post="bioavailability (0.7% in rats). SMEDDS was developed in an"/>
  <result pre="In vitro studies showed a sustained release behavior from SMEDDS." exact="Systemic" post="rat bioavailability was significantly higher in SMEDDS than in"/>
  <result pre="SMEDDS (filled diamonds) and marketed drug product (tablet) (filled squares);" exact="upper" post="right: accumulative release of oleanolic acid. Reproduced from [151]"/>
  <result pre="therapeutic potential, especially in the case of herb products against" exact="viral" post="infections. Further research on the mechanisms by which phytochemicals"/>
  <result pre="their analysis in biological materials – part II: antivirals against" exact="hepatitis" post="and HIV virusesJ Pharm Biomed Anal201814737839910.1016/j.jpba.2017.07.00329031512 3.SoltanMMZakiAKAntiviral screening of"/>
  <result pre="effect of Iranian herbal medicines against in vitro replication of" exact="herpes" post="simplex virusAvicenna J Phytomed20166550651527761420 6.GoncalvesJLLopesRCOliveiraDBCostaSSMirandaMMRomanosMTSantosNSWiggMDIn vitro anti-rotavirus activity of"/>
  <result pre="green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replicationAsian Pac J" exact="Cancer" post="Prev201516104199420210.7314/APJCP.2015.16.10.419926028072 9.LamSKNgTBA protein with antiproliferative, antifungal and HIV-1 reverse"/>
  <result pre="culture without toxic side effects or the tendency to induce" exact="viral" post="resistanceAntiviral Res2007761384710.1016/j.antiviral.2007.05.00217572513 13.RebensburgSHelferMSchneiderMKoppensteinerHEberleJSchindlerMGurtlerLBrack-WernerRPotent in vitro antiviral activity of Cistus"/>
  <result pre="activity of Cistus incanus extract against HIV and Filoviruses targets" exact="viral" post="envelope proteinsSci Rep201662039410.1038/srep2039426833261 14.XuHBMaYBHuangXYGengCAWangHZhaoYYangTHChenXLYangCYZhangXMChenJJBioactivity-guided isolation of anti-hepatitis B virus"/>
  <result pre="and nanoparticles of selenium on the immunogenicity of the inactivated" exact="avian influenza" post="virus subtype H9N2Vet Res Forum20156322723126893813 22.AshrafAAshrafMMRafiqeAAslamBGalaniSZafarSAsadFAsgharRDAkramSAhmedHShahSMAAsifRIn vivo antiviral potential"/>
  <result pre="Forum20156322723126893813 22.AshrafAAshrafMMRafiqeAAslamBGalaniSZafarSAsadFAsgharRDAkramSAhmedHShahSMAAsifRIn vivo antiviral potential of Glycyrrhiza glabra extract against" exact="Newcastle disease" post="virusPak J Pharm Sci2017302 Suppl56757228650322 23.AlfajaroMMKimHJParkJGRyuEHKimJYJeongYJKimDSHosmilloMSonKYLeeJHKwonHJRyuYBParkSJParkSILeeWSChoKOAnti-rotaviral effects of Glycyrrhiza"/>
  <result pre="22.AshrafAAshrafMMRafiqeAAslamBGalaniSZafarSAsadFAsgharRDAkramSAhmedHShahSMAAsifRIn vivo antiviral potential of Glycyrrhiza glabra extract against Newcastle" exact="disease" post="virusPak J Pharm Sci2017302 Suppl56757228650322 23.AlfajaroMMKimHJParkJGRyuEHKimJYJeongYJKimDSHosmilloMSonKYLeeJHKwonHJRyuYBParkSJParkSILeeWSChoKOAnti-rotaviral effects of Glycyrrhiza"/>
  <result pre="lignan biphenol derived from the Magnolia Tree, inhibits dengue virus" exact="type 2" post="infectionViruses2015794894491010.3390/v709285226378567 27.AstaniAReichlingJSchnitzlerPMelissa officinalis extract inhibits attachment of herpes simplex"/>
  <result pre="virus type 2 infectionViruses2015794894491010.3390/v709285226378567 27.AstaniAReichlingJSchnitzlerPMelissa officinalis extract inhibits attachment of" exact="herpes" post="simplex virus in vitroChemotherapy2012581707710.1159/00033559022377592 28.NolkemperSReichlingJStintzingFCCarleRSchnitzlerPAntiviral effect of aqueous extracts"/>
  <result pre="from species of the Lamiaceae family against Herpes simplex virus" exact="type 1" post="and type 2 in vitroPlanta Med200672151378138210.1055/s-2006-95171917091431 29.GeuenichSGoffinetCVenzkeSNolkemperSBaumannIPlinkertPReichlingJKepplerOTAqueous extracts from"/>
  <result pre="the Lamiaceae family against Herpes simplex virus type 1 and" exact="type 2" post="in vitroPlanta Med200672151378138210.1055/s-2006-95171917091431 29.GeuenichSGoffinetCVenzkeSNolkemperSBaumannIPlinkertPReichlingJKepplerOTAqueous extracts from peppermint, sage and"/>
  <result pre="densityRetrovirology200852710.1186/1742-4690-5-2718355409 30.ParsaniaMRezaeeMBMonavariSHJaimandKMousavi-JazayeriSMRazazianMNadjarhaMHAntiviral screening of four plant extracts against acyclovir resistant" exact="herpes" post="simplex virus type-1Pak J Pharm Sci2017304 Suppl1407141129043989 31.ChoiJGJinYHLeeHOhTWYimNHChoWKMaJYProtective effect"/>
  <result pre="effect of Panax notoginseng root water extract against influenza A" exact="virus infection" post="by enhancing antiviral interferon-mediated immune responses and natural killer"/>
  <result pre="of Panax notoginseng root water extract against influenza A virus" exact="infection" post="by enhancing antiviral interferon-mediated immune responses and natural killer"/>
  <result pre="sesquiterpenoid glycosides from Phyllanthus emblicaOrg Biomol Chem201412438764877410.1039/c4ob01196a25268491 35.OhCPriceJBrindleyMAWidrlechnerMPQuLMcCoyJAMurphyPHauckCMauryWInhibition of HIV-1" exact="infection" post="by aqueous extracts of Prunella vulgaris LVirol J2011818810.1186/1743-422X-8-18821513560 36.ZhangXAoZBelloARanXLiuSWigleJKobingerGYaoXCharacterization"/>
  <result pre="plant extractsJ Ethnopharmacol200177111311610.1016/S0378-8741(01)00265-311483387 41.JavedTAshfaqUARiazSRehmanSRiazuddinSIn-vitro antiviral activity of Solanum nigrum against" exact="hepatitis" post="C virusVirol J201182610.1186/1743-422X-8-2621247464 42.RehmanSIjazBFatimaNMuhammadSARiazuddinSTherapeutic potential of Taraxacum officinale against"/>
  <result pre="B virus activities of friedelolactones from Viola diffusa GingPhytomedicine2015227-872472910.1016/j.phymed.2015.05.00126141758 47.ArabzadehAMAnsari-DogahehMSharififarFShakibaieMHeidarbeigiMAnti" exact="herpes" post="simplex-1 activity of a standard extract of Zataria multiflora"/>
  <result pre="activityParasit Vectors2014713010.1186/1756-3305-7-13024678592 57.JohariJKianmehrAMustafaMRAbubakarSZandiKAntiviral activity of baicalein and quercetin against the" exact="Japanese encephalitis" post="virusInt J Mol Sci20121312167851679510.3390/ijms13121678523222683 58.LiYLLiKMSuMXLeungKTChenYWZhangYWStudies on antiviral constituents in"/>
  <result pre="Vectors2014713010.1186/1756-3305-7-13024678592 57.JohariJKianmehrAMustafaMRAbubakarSZandiKAntiviral activity of baicalein and quercetin against the Japanese" exact="encephalitis" post="virusInt J Mol Sci20121312167851679510.3390/ijms13121678523222683 58.LiYLLiKMSuMXLeungKTChenYWZhangYWStudies on antiviral constituents in"/>
  <result pre="leaves of Pithecellibium clypeariaZhongguo Zhong Yao Za Zhi200631539740016711425 59.BachmetovLGal-TanamyMShapiraAVorobeychikMGiterman-GalamTSathiyamoorthyPGolan-GoldhirshABenharITur-KaspaRZemelRSuppression of" exact="hepatitis" post="C virus by the flavonoid quercetin is mediated by"/>
  <result pre="flavonoid quercetin is mediated by inhibition of NS3 protease activityJ" exact="Viral" post="Hepat2012192e81e8810.1111/j.1365-2893.2011.01507.x22239530 60.GonzalezOFontanesVRaychaudhuriSLooRLooJArumugaswamiVSunRDasguptaAFrenchSWThe heat shock protein inhibitor Quercetin attenuates hepatitis"/>
  <result pre="activityJ Viral Hepat2012192e81e8810.1111/j.1365-2893.2011.01507.x22239530 60.GonzalezOFontanesVRaychaudhuriSLooRLooJArumugaswamiVSunRDasguptaAFrenchSWThe heat shock protein inhibitor Quercetin attenuates" exact="hepatitis" post="C virus productionHepatology20095061756176410.1002/hep.2323219839005 61.NakaneHOnoKDifferential inhibitory effects of some catechin"/>
  <result pre="effects of some catechin derivatives on the activities of human" exact="immunodeficiency" post="virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid"/>
  <result pre="activity against influenza virusesBiochem Biophys Res Commun20134401141910.1016/j.bbrc.2013.08.09024012672 63.ZhangWQiaoHLvYWangJChenXHouYTanRLiEApigenin inhibits enterovirus-71" exact="infection" post="by disrupting viral RNA association with trans-acting factorsPLoS One2014910e11042910.1371/journal.pone.011042925330384"/>
  <result pre="virusesBiochem Biophys Res Commun20134401141910.1016/j.bbrc.2013.08.09024012672 63.ZhangWQiaoHLvYWangJChenXHouYTanRLiEApigenin inhibits enterovirus-71 infection by disrupting" exact="viral" post="RNA association with trans-acting factorsPLoS One2014910e11042910.1371/journal.pone.011042925330384 64.QianSFanWQianPZhangDWeiYChenHLiXApigenin restricts FMDV"/>
  <result pre="viral RNA association with trans-acting factorsPLoS One2014910e11042910.1371/journal.pone.011042925330384 64.QianSFanWQianPZhangDWeiYChenHLiXApigenin restricts FMDV" exact="infection" post="and inhibits viral IRES driven translational activityViruses2015741613162610.3390/v704161325835532 65.ShibataCOhnoMOtsukaMKishikawaTGotoKMuroyamaRKatoNYoshikawaTTakataAKoikeKThe flavonoid"/>
  <result pre="with trans-acting factorsPLoS One2014910e11042910.1371/journal.pone.011042925330384 64.QianSFanWQianPZhangDWeiYChenHLiXApigenin restricts FMDV infection and inhibits" exact="viral" post="IRES driven translational activityViruses2015741613162610.3390/v704161325835532 65.ShibataCOhnoMOtsukaMKishikawaTGotoKMuroyamaRKatoNYoshikawaTTakataAKoikeKThe flavonoid apigenin inhibits hepatitis"/>
  <result pre="inhibits viral IRES driven translational activityViruses2015741613162610.3390/v704161325835532 65.ShibataCOhnoMOtsukaMKishikawaTGotoKMuroyamaRKatoNYoshikawaTTakataAKoikeKThe flavonoid apigenin inhibits" exact="hepatitis" post="C virus replication by decreasing mature microRNA122 levelsVirology2014462–463424810.1016/j.virol.2014.05.02425092460 66.HakobyanAArabyanEAvetisyanAAbroyanLHakobyanLZakaryanHApigenin"/>
  <result pre="C virus replication by decreasing mature microRNA122 levelsVirology2014462–463424810.1016/j.virol.2014.05.02425092460 66.HakobyanAArabyanEAvetisyanAAbroyanLHakobyanLZakaryanHApigenin inhibits" exact="African" post="swine fever virus infection in vitroArch Virol2016161123445345310.1007/s00705-016-3061-y27638776 67.SithisarnPMichaelisMSchubert-ZsilaveczMCinatlJJrDifferential antiviral"/>
  <result pre="by decreasing mature microRNA122 levelsVirology2014462–463424810.1016/j.virol.2014.05.02425092460 66.HakobyanAArabyanEAvetisyanAAbroyanLHakobyanLZakaryanHApigenin inhibits African swine fever" exact="virus infection" post="in vitroArch Virol2016161123445345310.1007/s00705-016-3061-y27638776 67.SithisarnPMichaelisMSchubert-ZsilaveczMCinatlJJrDifferential antiviral and anti-inflammatory mechanisms of"/>
  <result pre="decreasing mature microRNA122 levelsVirology2014462–463424810.1016/j.virol.2014.05.02425092460 66.HakobyanAArabyanEAvetisyanAAbroyanLHakobyanLZakaryanHApigenin inhibits African swine fever virus" exact="infection" post="in vitroArch Virol2016161123445345310.1007/s00705-016-3061-y27638776 67.SithisarnPMichaelisMSchubert-ZsilaveczMCinatlJJrDifferential antiviral and anti-inflammatory mechanisms of"/>
  <result pre="activity against dengue virusSci Rep20144545210.1038/srep0545224965553 70.ShiHRenKLvBZhangWZhaoYTanRXLiEBaicalin from Scutellaria baicalensis blocks" exact="respiratory" post="syncytial virus (RSV) infection and reduces inflammatory cell infiltration"/>
  <result pre="Rep20144545210.1038/srep0545224965553 70.ShiHRenKLvBZhangWZhaoYTanRXLiEBaicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV)" exact="infection" post="and reduces inflammatory cell infiltration and lung injury in"/>
  <result pre="medicine in vitroJ Vet Med Sci201678581982410.1292/jvms.15-057226902693 72.LiBQFuTDongyanYMikovitsJARuscettiFWWangJMFlavonoid baicalin inhibits HIV-1" exact="infection" post="at the level of viral entryBiochem Biophys Res Commun2000276253453810.1006/bbrc.2000.348511027509"/>
  <result pre="Sci201678581982410.1292/jvms.15-057226902693 72.LiBQFuTDongyanYMikovitsJARuscettiFWWangJMFlavonoid baicalin inhibits HIV-1 infection at the level of" exact="viral" post="entryBiochem Biophys Res Commun2000276253453810.1006/bbrc.2000.348511027509 73.HuangHZhouWZhuHZhouPShiXBaicalin benefits the anti-HBV therapy"/>
  <result pre="Res Commun2000276253453810.1006/bbrc.2000.348511027509 73.HuangHZhouWZhuHZhouPShiXBaicalin benefits the anti-HBV therapy via inhibiting HBV" exact="viral" post="RNAsToxicol Appl Pharmacol2017323364310.1016/j.taap.2017.03.01628322895 74.KongLLiSLiaoQZhangYSunRZhuXZhangQWangJWuXFangXZhuYOleanolic acid and ursolic acid: novel"/>
  <result pre="viral RNAsToxicol Appl Pharmacol2017323364310.1016/j.taap.2017.03.01628322895 74.KongLLiSLiaoQZhangYSunRZhuXZhangQWangJWuXFangXZhuYOleanolic acid and ursolic acid: novel" exact="hepatitis" post="C virus antivirals that inhibit NS5B activityAntiviral Res2013981445310.1016/j.antiviral.2013.02.00323422646 75.ZhaoCHXuJZhangYQZhaoLXFengBInhibition"/>
  <result pre="of a standardized elderberry liquid extract against clinically relevant human" exact="respiratory" post="bacterial pathogens and influenza A and B virusesBMC Complement"/>
  <result pre="a standardized elderberry liquid extract against clinically relevant human respiratory" exact="bacterial" post="pathogens and influenza A and B virusesBMC Complement Altern"/>
  <result pre="Pharm Sci20169114415310.1016/j.ejps.2016.06.01427328876 81.TangXJHuangKMGuiHWangJJLuJTDaiLJZhangLWangGPluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human" exact="glioblastoma" post="cellsInt J Nanomedicine2016114991500210.2147/IJN.S11430227757032 82.HongCDangYLinGYaoYLiGJiGShenHXieYEffects of stabilizing agents on the"/>
  <result pre="drying methodChin J Nat Med2014121718010.1016/S1875-5364(14)60012-124484600 103.ZhangJLvHJiangKGaoYEnhanced bioavailability after oral and" exact="pulmonary" post="administration of baicalein nanocrystalInt J Pharm2011420118018810.1016/j.ijpharm.2011.08.02321878378 104.LiuWTianRHuWJiaYJiangHZhangJZhangLPreparation and evaluation"/>
  <result pre="through ultra high performance liquid chromatography and mass spectrometry in" exact="cerebral" post="ischemiaDrug Res (Stuttg)2017671056457510.1055/s-0043-10956428561230 116.TranTHGuoYSongDBrunoRSLuXQuercetin-containing self-nanoemulsifying drug delivery system for"/>
  <result pre="143.JiPYuTLiuYJiangJXuJZhaoYHaoYQiuYZhaoWWuCNaringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and" exact="pulmonary" post="pharmacokineticsDrug Des Devel Ther20161091192510.2147/DDDT.S9773827041995 144.WangYWangSFirempongCKZhangHWangMZhangYZhuYYuJXuXEnhanced solubility and bioavailability of"/>
 </snippets>
</snippetsTree>
